Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Aspen Pharmacare (APNHY) had Tangible Shareholders Equity of $687.59M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.13B |
|
-- |
|
$4.16B |
|
$7.49B |
|
$964.03M |
|
$1.74B |
|
$1.85B |
|
$2.81B |
|
-- |
|
|
Tangible Shareholders Equity |
$687.59M |
$4.68B |
|
-- |
|
| Cash Flow Statement Financials | |
$284.26M |
|
$-287.40M |
|
$-8.93M |
|
$397.82M |
|
$353.14M |
|
$-44.69M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|